{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"congenital-adrenal-insufficiency-with-46-xy-sex-reversal-or-46-xy-disorder-of-sex-development-adrenal-insufficiency-due-to-cyp11a1-deficiency","columns":[{"gene":"","key":"population-6603015c5e779c6f332e","label":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","mondoId":"MONDO:0013400","onsetQualifier":null,"originColumnKey":"MONDO:0013400/OMIM:613743","originalViews":[{"key":"MONDO:0013400/OMIM:613743","label":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","scopeLabel":"OMIM:613743","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1d71d7b2583bdb4f6b9efe1639feb8521c9d6f9252fd4656b3823f60b0d4dba4","65667752f738a1f61adf464e08540f80c2674bae4631eb83b40b9b540873cf5c","6acbb080c57e28636e637506411184c1cb7fb3d2b3e0ca332120dfabdbf2fa3b","9580ddc96a9e3a2adbb0ae5c7892d55d81fe13379359089db015731d7ce26831","b7ef3c13428228f8f5f9bd13069545e970517dcf21eebf722d41cf08350b0fbb","d54a9a8c88102909390ab5c4c1c5966ddedf2cc2aa040b948def5b9da1395cb8"],"recordQualifiers":{},"scopeLabel":"OMIM:613743","sourceIds":["OMIM:613743"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-c8a2241bd718a807e906","label":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","mondoId":"MONDO:0013400","onsetQualifier":null,"originColumnKey":"MONDO:0013400/ORPHA:168558","originalViews":[{"key":"MONDO:0013400/ORPHA:168558","label":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","scopeLabel":"ORPHA:168558","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0bdce8b76cdfc96e32d2bac8fcd8ffa63f4d13d81e8cb73fe0a945725df9fa2c","14acb9aba5ffd8c8ea6c2cfd2eede3e3b00935ed0cf58de0fed6a85ead578114","14ec8d993e0632714b07a71e8cf1ce092cf784705edaa25a8ed79794bc382c69","2d5be626df7c2ed68c2785925a05fb97d3e3f6e04f7e91ef10ee61bce4462f02","327f2bbc42675c3e4c033860c02bd1ccb2274533e3065cbf60b8c8e72e8bd639","3b24c21a0cfed393163487fa313927bff433ec650c91471600e4589c4403dd2b","3b67bdd5346ca1ee5e0d9c830ad9f09de8fb681d65ecb148a16a746f58beba1a","3fae8fe0d093df66bcb0bbc25569b30a2ca5f62f734e75c7131a3c2aba434534","3fdb5e6d55dad5a9b5e2afad8426d69fe96f6c677bcea7113fa5b9a5d4ccba4b","42e7085f839d9e00a0f76054640e082848b7595be8a73e2e35d081c52a50c1d2","448f02916802696cf97fcbe0e3a39346804777ff4d8bae704fc5ff3c48edb12e","45435afad900f8bbe801e4fa8b57d9f8ac56153615ac917cc283a3699500f742","4f009fd0b7f4770024e02ebc49c9cf1aeac4b5db0ecf03a6de07f211a34a4dda","5460f6e105eef7b86fcbc68180b7aaa9c07f60521538afe6264cd5bd5379d4d1","573ca6dc0b8dfb23552395cad9305ae511e63e1f7fae40254e10ae8ec3e7c125","626e291e54567f6a5b4d48057caa57558f118e4a5af54e04362a82010d54555e","6373ccefcb64a087a39498ce5ae8705a47237f05bfde5ad7d08cb27db01e46c7","696ae312b778549712a9a7cc62d1d3ef3f690f5c82bfc7f6279b481bcd0b7c96","72108876b5fbc4e80e9b297ba35bc24a9627ab83098b5a71d97c2a228d375ae1","75e583dc2489da7cf547d08cfda21405767c8f7edae2bccf5bfabec5eea9d8c3","868b662f0881ae4b8550e34825d24a015c775f739f83d3eae0921672e59b0b20","869d9e6ab14444744f598a68045a22e656686c41e03f6bdc7687a99976ec7504","8d156713142e6ed726be72a03c58a939e7f7b4bcb243894a96ac9a5334a2c6e1","94e63a38a8c4a10af49a84f4f05b86b55c0584455a96d3a5f9cdca499b592fb5","983ef6bc4308514051e0c49a2bf4d8894f039334f85bee92264ba675cbc2342e","9da13c93f6e25b057494e1b05be19c3148dff82483e1ea7cfa6a2dc7f28431c0","a129f403d636b8fd2343fac88ff4955cc0e9180b11b8edba039bb9ed744faa90","aaa7b64fd42ba3afe278c569c45a65b3095a608ccd7575eb969d9249388f68ec","b6c56fdd3c5a096f98efe97ea0885a0ddf88998b1c0ff37718ce322fc265a0cd","ba82fec032bb6acf361b299e549c7e1d9c701a8cffa06ee4a2d32ddc27e45339","c0b1e2b40d641ed33cd935ece0716159add0ee5272faa6a7022e00c53b227b4d","c1d8ade1c6565977e22228ae155b14737058f276f09da7b7cd88e33e80ef0545","c26b419ec9604dcbff2c5c3428eee5e3bfc23d4dae576701c0d7d4269ae0cd4d","c74d63ef5ac2b4728762775ab725ce910409b7d9cb2142ab5b513a88de58add0","c90f3b7b388bb8a96d53752cbc0c03000d6f495bd62c5aa539435e9166c712f7","c96bd23049230ba289922c28155944d6af13d02cb2a8091e1c666ff97e6ef6ff","cc22adf2bc10c0159c79fe9b5d0375adbd6345d499ab5aecbe63eb55e90384ee","ceb71b1bfe339b9738e2f5b287b9fbff649d2b0c55ff3c2ee2cc86d5e2f48a15","d288dd4a56f11eb9d4564782399e0f53a73098b942d5c3b66bd6bbd173e37a53","dcf0d0b11afc50a5a77bbe7e724e90db5bf72d87993d3824a11db30419133ba8","ded19c38674bdc8b8bf3181e329eb099b5d7c6fda120b27bab30ee12f1239d52","e430d50fe98018e1362bc891c8c85763914d8a8326d24e195200e9a50bfca0b5","e6d21b6ca01e597e7774355d92b428d590e08f92d1b3fada18c277ab58f6274d","e7e06904ba0a9ae73c9ad61842278ce548d06e17e68bd7a2336591ea697a9c24","edcb0f629cb33e64c6d50cf0fbe04320cd448a3ce84d4c475f00d3157df81f71","efac91f8859bbe13b9c7d9723b3d1db82b06b99ae67d5086fc5df98f9d35d4a2","f5a160f94a47d4c2c4a39de9e12edeaa941f42cb511a1021889db4f8314369a5","f64ef2a7480694884b0517134c1bd388cf79100ee2df448570f0fcbcbfbc0862","f932dbcb7d48703ba026ca282c68c7a28dd6d42dbfd21ce1943530b9cf575e37","fb392f706d919e1bcd6576d4ffa9d92938a310a4601cc2d9a8f8ffc6c3578328"],"recordQualifiers":{},"scopeLabel":"ORPHA:168558","sourceIds":["ORPHA:168558"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6603015c5e779c6f332e","population-c8a2241bd718a807e906"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003107","HP:0012244","HP:0012598","HP:0000142","HP:0001197","HP:0010789","HP:0008187"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":56,"sourceGroups":{"omim":6,"orphanet":50}},"features":[{"hpoId":"HP:0003107","label":"Abnormal circulating cholesterol concentration","primary":true},{"hpoId":"HP:0012244","label":"Abnormal sex determination","primary":true},{"hpoId":"HP:0012598","label":"Abnormal urine potassium concentration","primary":true},{"hpoId":"HP:0000142","label":"Abnormal vagina morphology","primary":true},{"hpoId":"HP:0001197","label":"Abnormality of prenatal development or birth","primary":true},{"hpoId":"HP:0010789","label":"Abnormality of the Leydig cells","primary":true},{"hpoId":"HP:0008187","label":"Absence of secondary sex characteristics","primary":true},{"hpoId":"HP:0001941","label":"Acidosis","primary":false},{"hpoId":"HP:0000835","label":"Adrenal hypoplasia","primary":false},{"hpoId":"HP:0000846","label":"Adrenal insufficiency","primary":false},{"hpoId":"HP:0011749","label":"Adrenocorticotropic hormone excess","primary":false},{"hpoId":"HP:0001274","label":"Agenesis of corpus callosum","primary":false},{"hpoId":"HP:0000033","label":"Ambiguous genitalia, male","primary":false},{"hpoId":"HP:0000151","label":"Aplasia of the uterus","primary":false},{"hpoId":"HP:0008665","label":"Clitoral hypertrophy","primary":false},{"hpoId":"HP:0000028","label":"Cryptorchidism","primary":false},{"hpoId":"HP:0004319","label":"Decreased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0030349","label":"Decreased circulating androgen concentration","primary":false},{"hpoId":"HP:0008163","label":"Decreased circulating cortisol level","primary":false},{"hpoId":"HP:0000144","label":"Decreased fertility","primary":false},{"hpoId":"HP:0008734","label":"Decreased testicular size","primary":false},{"hpoId":"HP:0001944","label":"Dehydration","primary":false},{"hpoId":"HP:0000823","label":"Delayed puberty","primary":false},{"hpoId":"HP:0002750","label":"Delayed skeletal maturation","primary":false},{"hpoId":"HP:0008232","label":"Elevated circulating follicle stimulating hormone level","primary":false},{"hpoId":"HP:0011969","label":"Elevated circulating luteinizing hormone level","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0008730","label":"Female external genitalia in individual with 46,XY karyotype","primary":false},{"hpoId":"HP:0007574","label":"Generalized bronze hyperpigmentation","primary":false},{"hpoId":"HP:0007440","label":"Generalized hyperpigmentation","primary":false},{"hpoId":"HP:0000771","label":"Gynecomastia","primary":false},{"hpoId":"HP:0002153","label":"Hyperkalemia","primary":false},{"hpoId":"HP:0012605","label":"Hypernatriuria","primary":false},{"hpoId":"HP:0000953","label":"Hyperpigmentation of the skin","primary":false},{"hpoId":"HP:0002902","label":"Hyponatremia","primary":false},{"hpoId":"HP:0002615","label":"Hypotension","primary":false},{"hpoId":"HP:0011106","label":"Hypovolemia","primary":false},{"hpoId":"HP:0003154","label":"Increased circulating ACTH level","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0000848","label":"Increased circulating renin concentration","primary":false},{"hpoId":"HP:0030369","label":"Induced vaginal delivery","primary":false},{"hpoId":"HP:0000037","label":"Male pseudohermaphroditism","primary":false},{"hpoId":"HP:0012854","label":"Midshaft hypospadias","primary":false},{"hpoId":"HP:0001998","label":"Neonatal hypoglycemia","primary":false},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":false},{"hpoId":"HP:0001622","label":"Premature birth","primary":false},{"hpoId":"HP:0008207","label":"Primary adrenal insufficiency","primary":false},{"hpoId":"HP:0004349","label":"Reduced bone mineral density","primary":false},{"hpoId":"HP:0000127","label":"Renal salt wasting","primary":false},{"hpoId":"HP:0012245","label":"Sex reversal","primary":false},{"hpoId":"HP:0100779","label":"Urogenital sinus anomaly","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"A rare, genetic, developmental defect during embryogenesis disorder characterized by severe, early-onset, salt-wasting adrenal insufficiency and ambiguous/female external genitalia (irrespective of chromosomal sex) due to mutations in the CYP11A1 gene. Milder cases may present delayed onset of adrenal gland dysfunction and genitalia phenotype may range from normal male to female in individuals with 46,XY karyotype. Imaging studies reveal hypoplastic/absent adrenal glands and biochemical findings include low serum cortisol, mineralocorticoids, androgens, and sodium, with elevated potassium levels.","mondoId":"MONDO:0013400","node":{"canonicalSlug":"congenital-adrenal-insufficiency-with-46-xy-sex-reversal-or-46-xy-disorder-of-sex-development-adrenal-insufficiency-due-to-cyp11a1-deficiency","comparisons":[{"documentSha256":"9c98e4afbc10ea86e52ada17ba1eae3366992fcc366e03be4afd493c2890a262","key":"legacy-congenital-adrenal-insufficiency-with-46-xy-sex-reversal-or-46-xy-disorder-of-sex-development-adrenal-insufficiency-due-to-cyp11a1-deficiency","kind":"legacy","label":"Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency","memberIds":["MONDO:0013400"],"mondoId":"MONDO:0013400","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/congenital-adrenal-insufficiency-with-46-xy-sex-reversal-or-46-xy-disorder-of-sex-development-adrenal-insufficiency-due-to-cyp11a1-deficiency.9c98e4afbc10ea86e52ada17ba1eae3366992fcc366e03be4afd493c2890a262.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency","originalSourceId":"ORPHA:168558","paragraphs":["A rare, genetic, developmental defect during embryogenesis disorder characterized by severe, early-onset, salt-wasting adrenal insufficiency and ambiguous/female external genitalia (irrespective of chromosomal sex) due to mutations in the CYP11A1 gene. Milder cases may present delayed onset of adrenal gland dysfunction and genitalia phenotype may range from normal male to female in individuals with 46,XY karyotype. Imaging studies reveal hypoplastic/absent adrenal glands and biochemical findings include low serum cortisol, mineralocorticoids, androgens, and sodium, with elevated potassium levels."],"rawAttribution":"MONDO:0013400","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:01:49Z","upstream":"ORPHA:168558","url":"https://rarediseases.info.nih.gov/diseases/17033"},"ownColumnKeys":["population-6603015c5e779c6f332e","population-c8a2241bd718a807e906"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"adrenal gland disorder","mondoId":"MONDO:0005495","slug":null},{"kind":"parent","label":"46 XY differences of sex development","mondoId":"MONDO:0020040","slug":"46-xy-differences-of-sex-development"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0bdce8b76cdfc96e32d2bac8fcd8ffa63f4d13d81e8cb73fe0a945725df9fa2c","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012244","is_excluded":false,"label":"Abnormal sex determination","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14acb9aba5ffd8c8ea6c2cfd2eede3e3b00935ed0cf58de0fed6a85ead578114","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011106","is_excluded":false,"label":"Hypovolemia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14ec8d993e0632714b07a71e8cf1ce092cf784705edaa25a8ed79794bc382c69","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000151","is_excluded":false,"label":"Aplasia of the uterus","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1d71d7b2583bdb4f6b9efe1639feb8521c9d6f9252fd4656b3823f60b0d4dba4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011749","is_excluded":false,"label":"Adrenocorticotropic hormone excess","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"2d5be626df7c2ed68c2785925a05fb97d3e3f6e04f7e91ef10ee61bce4462f02","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012245","is_excluded":false,"label":"Sex reversal","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"327f2bbc42675c3e4c033860c02bd1ccb2274533e3065cbf60b8c8e72e8bd639","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001998","is_excluded":false,"label":"Neonatal hypoglycemia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b24c21a0cfed393163487fa313927bff433ec650c91471600e4589c4403dd2b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011969","is_excluded":false,"label":"Elevated circulating luteinizing hormone level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b67bdd5346ca1ee5e0d9c830ad9f09de8fb681d65ecb148a16a746f58beba1a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002750","is_excluded":false,"label":"Delayed skeletal maturation","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fae8fe0d093df66bcb0bbc25569b30a2ca5f62f734e75c7131a3c2aba434534","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008187","is_excluded":false,"label":"Absence of secondary sex characteristics","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fdb5e6d55dad5a9b5e2afad8426d69fe96f6c677bcea7113fa5b9a5d4ccba4b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012598","is_excluded":false,"label":"Abnormal urine potassium concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"42e7085f839d9e00a0f76054640e082848b7595be8a73e2e35d081c52a50c1d2","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"448f02916802696cf97fcbe0e3a39346804777ff4d8bae704fc5ff3c48edb12e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012854","is_excluded":false,"label":"Midshaft hypospadias","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"45435afad900f8bbe801e4fa8b57d9f8ac56153615ac917cc283a3699500f742","raw":{"aspect":"P","body_system":"breast","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000771","is_excluded":false,"label":"Gynecomastia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4f009fd0b7f4770024e02ebc49c9cf1aeac4b5db0ecf03a6de07f211a34a4dda","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5460f6e105eef7b86fcbc68180b7aaa9c07f60521538afe6264cd5bd5379d4d1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001941","is_excluded":false,"label":"Acidosis","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"573ca6dc0b8dfb23552395cad9305ae511e63e1f7fae40254e10ae8ec3e7c125","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000144","is_excluded":false,"label":"Decreased fertility","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"626e291e54567f6a5b4d48057caa57558f118e4a5af54e04362a82010d54555e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002902","is_excluded":false,"label":"Hyponatremia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6373ccefcb64a087a39498ce5ae8705a47237f05bfde5ad7d08cb27db01e46c7","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"65667752f738a1f61adf464e08540f80c2674bae4631eb83b40b9b540873cf5c","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012245","is_excluded":false,"label":"Sex reversal","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"696ae312b778549712a9a7cc62d1d3ef3f690f5c82bfc7f6279b481bcd0b7c96","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008163","is_excluded":false,"label":"Decreased circulating cortisol level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6acbb080c57e28636e637506411184c1cb7fb3d2b3e0ca332120dfabdbf2fa3b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"72108876b5fbc4e80e9b297ba35bc24a9627ab83098b5a71d97c2a228d375ae1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000028","is_excluded":false,"label":"Cryptorchidism","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"75e583dc2489da7cf547d08cfda21405767c8f7edae2bccf5bfabec5eea9d8c3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000142","is_excluded":false,"label":"Abnormal vagina morphology","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"868b662f0881ae4b8550e34825d24a015c775f739f83d3eae0921672e59b0b20","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004349","is_excluded":false,"label":"Reduced bone mineral density","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"869d9e6ab14444744f598a68045a22e656686c41e03f6bdc7687a99976ec7504","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030369","is_excluded":false,"label":"Induced vaginal delivery","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8d156713142e6ed726be72a03c58a939e7f7b4bcb243894a96ac9a5334a2c6e1","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001197","is_excluded":false,"label":"Abnormality of prenatal development or birth","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94e63a38a8c4a10af49a84f4f05b86b55c0584455a96d3a5f9cdca499b592fb5","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007574","is_excluded":false,"label":"Generalized bronze hyperpigmentation","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9580ddc96a9e3a2adbb0ae5c7892d55d81fe13379359089db015731d7ce26831","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000953","is_excluded":false,"label":"Hyperpigmentation of the skin","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"983ef6bc4308514051e0c49a2bf4d8894f039334f85bee92264ba675cbc2342e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000823","is_excluded":false,"label":"Delayed puberty","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9da13c93f6e25b057494e1b05be19c3148dff82483e1ea7cfa6a2dc7f28431c0","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002615","is_excluded":false,"label":"Hypotension","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a129f403d636b8fd2343fac88ff4955cc0e9180b11b8edba039bb9ed744faa90","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002153","is_excluded":false,"label":"Hyperkalemia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aaa7b64fd42ba3afe278c569c45a65b3095a608ccd7575eb969d9249388f68ec","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000835","is_excluded":false,"label":"Adrenal hypoplasia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b6c56fdd3c5a096f98efe97ea0885a0ddf88998b1c0ff37718ce322fc265a0cd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b7ef3c13428228f8f5f9bd13069545e970517dcf21eebf722d41cf08350b0fbb","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000846","is_excluded":false,"label":"Adrenal insufficiency","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ba82fec032bb6acf361b299e549c7e1d9c701a8cffa06ee4a2d32ddc27e45339","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008232","is_excluded":false,"label":"Elevated circulating follicle stimulating hormone level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0b1e2b40d641ed33cd935ece0716159add0ee5272faa6a7022e00c53b227b4d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000127","is_excluded":false,"label":"Renal salt wasting","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c1d8ade1c6565977e22228ae155b14737058f276f09da7b7cd88e33e80ef0545","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000848","is_excluded":false,"label":"Increased circulating renin concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c26b419ec9604dcbff2c5c3428eee5e3bfc23d4dae576701c0d7d4269ae0cd4d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011749","is_excluded":false,"label":"Adrenocorticotropic hormone excess","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c74d63ef5ac2b4728762775ab725ce910409b7d9cb2142ab5b513a88de58add0","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008730","is_excluded":false,"label":"Female external genitalia in individual with 46,XY karyotype","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c90f3b7b388bb8a96d53752cbc0c03000d6f495bd62c5aa539435e9166c712f7","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001622","is_excluded":false,"label":"Premature birth","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c96bd23049230ba289922c28155944d6af13d02cb2a8091e1c666ff97e6ef6ff","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007440","is_excluded":false,"label":"Generalized hyperpigmentation","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc22adf2bc10c0159c79fe9b5d0375adbd6345d499ab5aecbe63eb55e90384ee","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008734","is_excluded":false,"label":"Decreased testicular size","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ceb71b1bfe339b9738e2f5b287b9fbff649d2b0c55ff3c2ee2cc86d5e2f48a15","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000033","is_excluded":false,"label":"Ambiguous genitalia, male","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d288dd4a56f11eb9d4564782399e0f53a73098b942d5c3b66bd6bbd173e37a53","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003154","is_excluded":false,"label":"Increased circulating ACTH level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d54a9a8c88102909390ab5c4c1c5966ddedf2cc2aa040b948def5b9da1395cb8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000127","is_excluded":false,"label":"Renal salt wasting","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"dcf0d0b11afc50a5a77bbe7e724e90db5bf72d87993d3824a11db30419133ba8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001944","is_excluded":false,"label":"Dehydration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ded19c38674bdc8b8bf3181e329eb099b5d7c6fda120b27bab30ee12f1239d52","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030349","is_excluded":false,"label":"Decreased circulating androgen concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e430d50fe98018e1362bc891c8c85763914d8a8326d24e195200e9a50bfca0b5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008665","is_excluded":false,"label":"Clitoral hypertrophy","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6d21b6ca01e597e7774355d92b428d590e08f92d1b3fada18c277ab58f6274d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004319","is_excluded":false,"label":"Decreased circulating aldosterone concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e7e06904ba0a9ae73c9ad61842278ce548d06e17e68bd7a2336591ea697a9c24","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012605","is_excluded":false,"label":"Hypernatriuria","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edcb0f629cb33e64c6d50cf0fbe04320cd448a3ce84d4c475f00d3157df81f71","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003107","is_excluded":false,"label":"Abnormal circulating cholesterol concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"efac91f8859bbe13b9c7d9723b3d1db82b06b99ae67d5086fc5df98f9d35d4a2","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008207","is_excluded":false,"label":"Primary adrenal insufficiency","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f5a160f94a47d4c2c4a39de9e12edeaa941f42cb511a1021889db4f8314369a5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001274","is_excluded":false,"label":"Agenesis of corpus callosum","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f64ef2a7480694884b0517134c1bd388cf79100ee2df448570f0fcbcbfbc0862","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100779","is_excluded":false,"label":"Urogenital sinus anomaly","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f932dbcb7d48703ba026ca282c68c7a28dd6d42dbfd21ce1943530b9cf575e37","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010789","is_excluded":false,"label":"Abnormality of the Leydig cells","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fb392f706d919e1bcd6576d4ffa9d92938a310a4601cc2d9a8f8ffc6c3578328","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000037","is_excluded":false,"label":"Male pseudohermaphroditism","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17033\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013400\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:168558</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic, developmental defect during embryogenesis disorder characterized by severe, early-onset, salt-wasting adrenal insufficiency and ambiguous/female external genitalia (irrespective of chromosomal sex) due to mutations in the CYP11A1 gene. Milder cases may present delayed onset of adrenal gland dysfunction and genitalia phenotype may range from normal male to female in individuals with 46,XY karyotype. Imaging studies reveal hypoplastic/absent adrenal glands and biochemical findings include low serum cortisol, mineralocorticoids, androgens, and sodium, with elevated potassium levels.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17033\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"congenital-adrenal-insufficiency-with-46-xy-sex-reversal-or-46-xy-disorder-of-sex-development-adrenal-insufficiency-due-to-cyp11a1-deficiency","sourceDocuments":[{"name":"GARD: Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency","reviewed":null,"source_release":"2026-10-21T17:01:49Z","url":"https://rarediseases.info.nih.gov/diseases/17033"},{"name":"MONDO: Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013400"}],"sourceNote":"","synonyms":["adrenal insufficiency, congenital, with 46,XY SEX reversal, partial or complete","adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","cholesterol side-chain cleavage deficiency","p450scc deficiency","XY sex reversal-adrenal failure","XY sex reversal-adrenal failure syndrome"],"takeawayHtml":"","title":"Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency"},"schemaVersion":1}
